Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by 4D pharma plc 4D pharma plc (“4D pharma”) Receives Notice of Delisting From Nasdaq June 28, 2022 From 4D pharma plc Via Business Wire Tickers LBPS 4D pharma Presents Trial in Progress Poster on Study of MRx0518 in Combination with BAVENCIO® in Patients with Unresectable Locally Advanced or Metastatic Urothelial Carcinoma at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting May 26, 2022 From 4D pharma plc Via Business Wire Tickers LBPS 4D pharma Reports Full Year 2021 Financial Results, Operational Highlights, and Guidance for Key Milestones in 2022 March 31, 2022 From 4D pharma plc Via Business Wire Tickers LBPS 4D pharma Announces FDA Clearance of IND Application for Live Biotherapeutics MRx0005 and MRx0029 for the Treatment of Parkinson’s Disease February 22, 2022 From 4D pharma plc Via Business Wire Tickers LBPS 4D pharma to Host Virtual KOL Event Discussing Asthma Treatment Landscape and Review of Positive Topline Results from Part A of Phase I/II Trial of MRx-4DP0004 January 20, 2022 From 4D pharma plc Via Business Wire Tickers LBPS 4D pharma to Present at the H.C. Wainwright BioConnect Conference January 05, 2022 From 4D pharma plc Via Business Wire Tickers LBPS 4D pharma appoints John Doyle as Chief Financial Officer January 03, 2022 From 4D pharma plc Via Business Wire Tickers LBPS 4D Pharma Announces Positive Topline Results From Part a of Phase I/II Trial of MRx-4DP0004 for the Treatment of Asthma December 13, 2021 From 4D pharma plc Via Business Wire Tickers LBPS 4D pharma Presents Microbiome Analyses from Phase II Clinical Trial of Blautix® for IBS-C and IBS-D at Gastro 2021 December 09, 2021 From 4D pharma plc Via Business Wire Tickers LBPS 4D pharma to Participate in Jefferies London Healthcare Conference November 11, 2021 From 4D pharma plc Via Business Wire Tickers LBPS 4D pharma Presents Two Clinical Posters for Live Biotherapeutic MRx0518 at the European Society for Medical Oncology (ESMO) Congress 2021 September 15, 2021 From 4D pharma plc Via Business Wire Tickers LBPS 4D pharma Announces Two Presentations at European Society for Medical Oncology (ESMO) Congress 2021 August 02, 2021 From 4D pharma plc Via Business Wire Tickers LBPS 4D pharma Announces $30 Million Credit Facility with Oxford Finance July 29, 2021 From 4D pharma plc Via Business Wire Tickers LBPS 4D pharma Announces Passing of Chief Financial Officer John Beck July 26, 2021 From 4D pharma plc Via Business Wire Tickers LBPS 4D pharma Announces Publication of Preclinical Research Showing Single Strain Megasphaera massiliensis improves activity of CAR-T July 06, 2021 From 4D pharma plc Via Business Wire Tickers LBPS 4D pharma to Participate in Ladenburg Thalmann Healthcare Conference June 29, 2021 From 4D pharma plc Via Business Wire Tickers LBPS 4D pharma to Present at the Microbiome Movement Drug Development Summit June 22, 2021 From 4D pharma plc Via Business Wire Tickers LBPS 4D pharma Completes Enrollment of Part A of the Phase I/II Trial of MRx-4DP0004 for the Treatment of Asthma and Provides Program Update June 04, 2021 From 4D pharma plc Via Business Wire Tickers LBPS 4D pharma Presents Additional Positive Results of Phase II Study of Blautix® for the Treatment of Irritable Bowel Syndrome May 24, 2021 From 4D pharma plc Via Business Wire Tickers LBPS 4D pharma to Present Additional Data from Phase II Study of Blautix for the Treatment of Irritable Bowel Syndrome at Digestive Disease Week (DDW) 2021 May 17, 2021 From 4D pharma plc Via Business Wire Tickers LBPS 4D pharma Collaborates With Parkinson’s UK to Establish Patient Advisory Board April 19, 2021 From 4D pharma plc Via Business Wire Tickers LBPS Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
